CA Patent

CA2550811C — Temperature-stable formulations, and methods of development thereof

Assigned to Lupin Atlantis Holdings SA · Expires 2012-05-01 · 14y expired

What this patent protects

One embodiment of the present invention relates to a method of preparing a concentrated pharmaceutical formulation, comprising the steps of: combining in a container a therapeutic agent, a solvent and at least one pharmaceutically acceptable excipient to give a solution; adding t…

USPTO Abstract

One embodiment of the present invention relates to a method of preparing a concentrated pharmaceutical formulation, comprising the steps of: combining in a container a therapeutic agent, a solvent and at least one pharmaceutically acceptable excipient to give a solution; adding to said solution a seed crystal of said compound to give a heterogeneous mixture; and observing the stability of said heterogeneous mixture.

Drugs covered by this patent

Patent Metadata

Patent number
CA2550811C
Jurisdiction
CA
Classification
—
Expires
2012-05-01
Drug substance claim
No
Drug product claim
No
Assignee
Lupin Atlantis Holdings SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.